Lab Reagents
Human IgG antibody Laboratories manufactures the antibody resistant mutant virus reagents distributed by Genprice. The Antibody Resistant Mutant Virus reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact virus Antibody. Other Antibody products are available in stock. Specificity: Antibody Category: Resistant Group: Mutant Virus
Mutant Virus information
Mutant EGFR inhibitor |
|
B1103-50 |
ApexBio |
50 mg |
EUR 3316.8 |
|
Description: Mutant EGFR inhibitor is a selective and potent Mutated EGFR inhibitor(L858R activating mutant, the Exonl9 deletion activating mutant and the T790M resistance mutant). |
Mutant p53 recombinant monoclonal antibody |
|
A5857 |
Bimake |
100ul X 3 |
EUR 714 |
|
|
|
Description: A recombinant monoclonal antibody from rabbit against human Mutant p53 for WB, IF,ELISA |
Polyclonal SUMO4 Antibody (V55 Mutant) |
|
APR03726G |
Leading Biology |
0.1ml |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SUMO4 (V55 Mutant). This antibody is tested and proven to work in the following applications: |
Mutant Isocitrate Dehydrogenase (Mutant IDH) Activity Assay Kit (Colorimetric) |
|
K985-100 |
Biovision |
|
EUR 679.2 |
Methicillin-Resistant Staphylococcus Aureus Antibody |
|
20-abx137142 |
Abbexa |
|
|
|
|
Amyloid Precursor Protein (Frameshift Mutant) Antibody |
|
abx022541-02ml |
Abbexa |
0.2 ml |
EUR 610.8 |
|
|
Monoclonal EGFR mutant Antibody, Clone: 5G9B5 |
|
AMM03123G |
Leading Biology |
0.1ml |
EUR 633.6 |
|
Description: A Monoclonal antibody against Human EGFR mutant. The antibodies are raised in Mouse and are from clone 5G9B5. This antibody is applicable in WB and IHC, FC, E |
Monoclonal EGFR mutant Antibody, Clone: 5G9B5 |
|
AMM03124G |
Leading Biology |
0.1ml |
EUR 633.6 |
|
Description: A Monoclonal antibody against Human EGFR mutant. The antibodies are raised in Mouse and are from clone 5G9B5. This antibody is applicable in WB and IHC, FC, E |
Anti-Mutant p53 Rabbit Monoclonal Antibody |
|
M00001-3 |
BosterBio |
100ug/vial |
EUR 476.4 |
|
Description: Rabbit Monoclonal Mutant p53 Antibody. Validated in IP, IF, WB and tested in Human. |
IDH1 Antibody / Isocitrate Dehydrogenase (R132H mutant) |
|
V9378-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
|
Description: IDH1 R132H antibody binds to IDH1-mutated protein, but does not bind the wild-type IDH1 protein. IDH1 R132H point mutations are frequently seen in World Health Organization grade II and III gliomas and are believed to constitute an early step in tumorigenesis. IDH1 R132H can be used as a diagnostic marker to help differentiate infiltrating gliomas from gliosis, and as a prognostic marker for gliomas and secondary glioblastoma multiforme. IDH1 R132H antibody shows strong cytoplasmic staining and weaker nuclear staining in tumor cells with the R132H-mutated peptide. Diffuse staining of the fibrillary tumor matrix is also seen. |
IDH1 Antibody / Isocitrate Dehydrogenase (R132H mutant) |
|
V9378-20UG |
NSJ Bioreagents |
20ug |
EUR 219 |
|
Description: IDH1 R132H antibody binds to IDH1-mutated protein, but does not bind the wild-type IDH1 protein. IDH1 R132H point mutations are frequently seen in World Health Organization grade II and III gliomas and are believed to constitute an early step in tumorigenesis. IDH1 R132H can be used as a diagnostic marker to help differentiate infiltrating gliomas from gliosis, and as a prognostic marker for gliomas and secondary glioblastoma multiforme. IDH1 R132H antibody shows strong cytoplasmic staining and weaker nuclear staining in tumor cells with the R132H-mutated peptide. Diffuse staining of the fibrillary tumor matrix is also seen. |
IDH1 Antibody / Isocitrate Dehydrogenase (R132H mutant) |
|
V9378SAF-100UG |
NSJ Bioreagents |
100ug |
EUR 499 |
|
Description: IDH1 R132H antibody binds to IDH1-mutated protein, but does not bind the wild-type IDH1 protein. IDH1 R132H point mutations are frequently seen in World Health Organization grade II and III gliomas and are believed to constitute an early step in tumorigenesis. IDH1 R132H can be used as a diagnostic marker to help differentiate infiltrating gliomas from gliosis, and as a prognostic marker for gliomas and secondary glioblastoma multiforme. IDH1 R132H antibody shows strong cytoplasmic staining and weaker nuclear staining in tumor cells with the R132H-mutated peptide. Diffuse staining of the fibrillary tumor matrix is also seen. |
Ovine Recombinant (E.Coli) Purified Leptin Quadruple mutant mutant Antagonist Protein |
|
LEP26-QM-10 |
Alpha Diagnostics |
10 ug |
EUR 196.8 |
